Anti-HIV Medications and Structured Treatment Interruptions for People Recently Infected With HIV
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
People recently infected with HIV who are treated with anti-HIV medications may develop
strong immune system responses to HIV and may be able to control the virus without continuing
to take these medications. The purpose of this study is to see if giving anti-HIV medications
to people soon after they have been infected with HIV can help them control HIV. The study
will also see if the immune system can control the amount of HIV virus in the blood (viral
load) even after a person has stopped taking the medications. The study will evaluate three
different schedules of stopping and starting anti-HIV medications to see which schedule is
best able to boost a patient's immune system to control HIV viral load.
Hypothesis: Combination therapy started in primary HIV infection, in conjunction with
structured treatment interruptions, will result in greater control of viremia off treatment
than induction therapy alone.
Phase:
N/A
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)